Biotech Stock News (SYN) (ZFGN) (ARNA) (OREX) (VVUS)

Synthetic Biologics (NYSE:SYN) On Thursday December 3, 2015 Synthetic Biologics announced positive phase 2 results for the prevention of a bacterial infection known as C. difficile. The drug the company is using to combat against this bacterial infection is known as SYN-004. This drug was created for the purpose of clearing out IV fluid, such … Read more